The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1
Status:
Not yet recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
To assess the safety and effectiveness of treatment with an intracanalicular dexamethasone
(0.4mg) insert in the operating room following cataract surgery/intraocular lens implant
(IOL) compared to insertion 1-day post-op.